Our previous findings showed that the combination of a recombinant adenovirus encoding human endostatin (Ad-E) and αPD-1 antibody (mAb) improves the anti-tumor efficacy of mouse cancer models, promoting the activated immune response indicated by features such as enhanced T cell infiltration and inhibiting tumor growth. Here, COL18A1 is linked to neoplasm.